Arie Marcovich

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.